Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Detection Technology establishes a talent hub to Nanjing

Detection Technology Plc press release 22 December 2021 at 13:00 (EET) Detection Technology, a global leader in X-ray detector solutions, announced today that it will establish a talent hub in Nanjing, China to boost the development of its offering beyond hardware. The talent hub will be operational at the beginning of 2022, and recruitment has already started. The Nanjing talent hub will be profiled as a competence pool of software, algorithm, firmware, and electronics developers. “Software-driven detector solutions are on their way. For 30 years, we have been at the frontier of

AddLife has reached an agreement with the majority-owner to acquire MBA Incorporado S.L, a leading Spanish orthopaedic and trauma surgery business

AddLife is continuing its expansion in Europe and has today made an offer to acquire all the shares in MBA Incorporado S.L (“MBA”), which has been accepted by Alantra Private Equity that owns approximately 75 percent of the shares. The agreed purchase price for 100 percent of the equity amounts to EUR 111 million cash and signing of the sale and purchase agreement for all shares, as well as completion, is intended for January 2022. MBA is a leading independent orthopaedic surgery distributor with operations in Spain, Italy and Portugal. The company has a turnover of approximately EUR 67

FluoGuide has submitted a Clinical Trial Application (CTA) to the Danish Medicines Agency to initiate phase II trial with FG001 in lung cancer

Copenhagen, Denmark, 22 December 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) is delighted to announce that the company has submitted a CTA to initiate the phase II trial in lung cancer. The clinical trial will be conducted at Rigshospitalet in Denmark.Following approval from the Danish Medicines Agency, FluoGuide will initiate the phase II trial in lung cancer in collaboration with Department of Cardiothoracic Surgery at the University Hospital, Rigshospitalet, in Denmark. The phase II trial is designed to enrol up to 24 patients with non small cell lung cancer (NSCLC). The

Ride BidCo AB publishes a supplement to the offer document regarding its recommended cash offer to the shareholders of Nobina AB (publ)

This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand, Singapore or South Africa or in any other jurisdiction where such offer would be prohibited by applicable law pursuant to legislation, restrictions and regulations in the relevant jurisdiction. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled "Important notice" at the end of

YIT and Sirius Capital Partners to establish a co-investment for Finnish residential investments

YIT and a newly-established affiliate of Sirius Capital Partners, have agreed to establish a co-investment vehicle investing in build-to-rent residential assets in Finland. In connection, YIT has agreed to sell 18 build-to-rent residential projects to the co-investment vehicle for a purchase price of EUR 164 million. The portfolio comprises 754 rental apartments, the majority of the assets are located in the greater Helsinki region. YIT’s share of the co-investment will be 20%. The construction of the projects will take place during 2022-2024.  “The co-investment model allows YIT to

Receives credit facility of SEK 15 million

M.O.B.A. Network AB has received a credit promise of a credit facility of SEK 15 million from the bank Nordea. The agreement provides increased funding to support M.O.B.A. Network's continued expansion and growth plans. The new credit increases M.O.B.A. Network's flexibility with potential acquisitions and further investments in existing operations. "We are very pleased to be able to expand our collaboration with Nordea. The credit facility gives us additional financial strength and room to maneuver in the short and long term," says Björn Mannerqvist, CEO. In addition to the credit

Citycon continues to execute on the 300,000 sqm residential potential across the Nordics

CITYCON OYJ Corporate Press Release 22 December 2021 Construction of the Company’s Herkules Park in Skien, Norway continues to progress. Citycon aims to be the leading owner and developer of urban community hubs in the Nordics, ongoing construction of residentials in Finland, Sweden and Norway and the continued progress of outstanding residential projects such as Herkules Park in Skien, Norway signals the company’s commitment to this strategy. Construction of this unique residential project will complement and enhance Citycon’s existing necessity-based retail asset, Herkules

Ongoing installation of collectors at Iberafrica in Nairobi

Absolicon team on site in Kenya to install collectors for a 400 sqm solar field at Iberafrica Power (E.A.) Limited in Nairobi. The solar thermal field is made in collaboration with Absolicon partner Ariya Finergy and is the first step towards a robotized production line in Kenya.In line with its climate change agenda and ongoing cost management initiatives, power producer Iberafrica identified the Absolicon T160 solar thermal collectors as an ideal solution to offset its carbon footprint and provide much needed process heating for the power plant. The solar thermal installation is

Peab builds rental apartments in Malmö

Peab has been commissioned to build 73 rental apartments in Hyllie in southern Malmö. The customer is Trianon and the contract is worth SEK 108 million.Peab will build three apartment buildings in varying heights. The buildings facing the boulevard and square will be three to five floors with 30 apartments and commercial space on the bottom. The buildings in the courtyard will be three stories with 43 apartments. “We’re proud to contribute with our expertise and to build more homes in this expanding city borough in Malmö. The apartments have a great location alongside the boulevard right

Sedana Medical applies for market approval in Italy

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the company has submitted an application for market approval for Sedaconda (isoflurane) for inhaled sedation in intensive care in Italy.“With the application in Italy, we are hoping to bring our Sedaconda products to yet another important European market. Having received market approval in 14 European countries to date, we are aiming to receive further approvals in Poland, Italy, Switzerland, and the UK during 2022. This would allow us to offer the first and only on-label therapy for inhaled sedation of mechanically

ADDvise Group changes listing to Nasdaq First North Premier

ADDvise Group has applied to trade on Nasdaq First North Premier and has today received an approval. ADDvise Group changes its listing on 23 December 2021. Nasdaq First North Premier gives companies the opportunity to prepare for listing on the Nasdaq Main Market by setting higher requirements for information disclosure, corporate governance and financial reporting. ADDvise Group's shareholders do not need to take any action in connection with the listing on Nasdaq First North Premier. The company's shares will be traded under the same short name and ISIN codes as before. For further

Scandinavian ChemoTech achieves clinical success within the subsidiary Vetiqure AB

After the treating veterinarian at Evidensia Specialist Animal Hospital Helsingborg carried out the last follow-up of the dog that was treated in the autumn of 2021, a very good clinical result can be confirmed.During the late summer, the Company's subsidiary within Animal Care began a collaboration with Evidensia Specialist Animal Hospital Helsingborg, where vetIQure™ with its Tumour Specific Electroporation technology (TSE) is currently being evaluated on both small animals and horses. “A dog with a giant cell tumour in the palate has been treated with a positive outcome. It was a very

Robert Rönn, SVP and Head of R&D: “My vision is to develop several new drugs based on amorphOX™”

In recent years, Orexo has invested in its development pipeline with a focus on OX124, a life-saving overdose medication. In parallel, the company has developed a new drug delivery platform, amorphOX™, that will serve as the backbone in other future pharmaceuticals. In an interview with Robert Rönn, SVP and Head of Research and Development at Orexo, he reflects on creating pioneering pharmaceuticals, filing successful patents and his vision for the new drug delivery platform.   [P:\Internal Information\Robert Robert Rönn, SVP and Head of R&D atRönn\JELA_OREX_210906 Orexo

Commercial breakthrough is in the cards for Zwipe

Season's Greetings from André Løvestam, CEO of ZwipeOSLO, NORWAY - 22 December 2021 With our eyes set on the long-awaited commercial breakthrough for Zwipe which now seems highly likely to happen in 2022, we have spent the last four years undergoing a transformation which has laid the foundation for Zwipe’s long-term success: · Our organization has been significantly strengthened, and is continually being uplifted, based on a philosophy of “a black belt in every seat.” · Our technology platform has been revolutionized to a cutting edge, third generation, single silicon platform

Valmet to supply oxygen delignification system to Arkhangelsk Pulp and Paper Mill in Russia

Valmet Oyj’s press release on December 22, 2021 at 11:00 a.m. EETValmet will deliver an oxygen delignification system, including additional Valmet TwinRoll presses to Arkhangelsk’s Pulp and Paper Mill in Novodvinsk, Russia. The order includes both technology and automation deliveries. The start-up of the new systems is scheduled for the second half of 2022. The order was included in Valmet's orders received of the third quarter 2021. The value of the order will not be disclosed. However, a delivery with this scope of supply is usually valued between EUR 10-15 million. “Our

Directorate Change

Board Appointment 22 December 2021 EnQuest PLC ('EnQuest') is pleased to announce its intention to appoint Rani Koya as a Non-Executive Director of the EnQuest Board with effect from 1 January 2022.  On joining the Board, Rani will become a member of the Technical and Reserves Committee. Rani has worked extensively in major energy companies in a variety of technical, project management and executive management roles across the globe. She is currently the CEO of a renewable energy company. Martin Houston, Chairman of EnQuest: "I am delighted to welcome Rani to the Board of

In an historic vote, Italy to ban fur farming and shut down all mink farms within six months

Humane Society International in Italy hails ‘an historic victory’ROME, 21 December 2021 – The Budget Committee of the Italian Senate today voted to approve a modified version of an amendment  to the budget law which will see the country’s 10 remaining mink fur farms closed within six months and a permanent ban on fur farming throughout Italy.  The vote follows discussions with animal protection organisation Humane Society International/Europe which presented practical, strategic solutions

Minesto announces commercially relevant power production for its next-generation Dragon Class tidal energy kites

Leading marine energy developer Minesto today announces that, based on analysed production data and verified simulations, its utility-scale Dragon Class tidal energy power plants are each projected to produce 3.5 GWh of clean electricity per year at identified sites.“Based on the technology’s current performance and simulations, Minesto’s next-generation marine energy power plants will be commercially ready to demonstrate the viability of ocean energy as a valuable baseload contribution to the net-zero energy mix”, said Dr Martin Edlund, CEO of Minesto.  The power output projection is

Ida Geiler appointed CEO of Synsam Group's Production and Innovation Center in Östersund

The site for Synsam Group's new Production and Innovation Center on Frösön outside Östersund will be completed during the spring of 2022. Ida Geiler, who is currently the project manager for Synsam Group's relocation of the spectacle production from Asia to Sweden, has been appointed CEO of Synsam Group's Production and Innovation Center. Ida will assume her position on 3 January 2022.Ida Geiler has led business development and transformation projects within production for several different companies and in different industries, with good results in the past couple of years of her career.

Bravida Norway wins two major contracts for the new Nordmøre and Romsdal Hospital

Bravida Norway has been awarded contracts for the new Nordmøre and Romsdal Hospital (SNR) to supply electrical and telecommunications technology, with an order value of NOK 390 million, and security systems, with an order value of NOK 15 million.SNR consists of an emergency hospital in Hjelset outside Molde, and a medical centre in Kristiansund. Bravida’s contracts cover the supplying of technology to the hospital in Hjelset, which consists of 60,000 square metres of new construction. The project will create a state-of-the-art hospital complex that shortens waiting times and ensures

Updated Guidance 2021 and 2022 for Trophy Games Development A/S

- Company Announcement No. 12-2021  Copenhagen, December 22, 2021  *Contains Inside Information*   Revenue • 2021: Full year revenue growth 2021 vs 2020 for game portfolio expected to be between 33-36%, corresponding to DKK 41.0-42.0m compared to latest guidance of DKK 44.7m.  • 2022: Full year revenue 2022 vs 2021 expected to be between DKK 70.0–80.0m compared to DKK 77.9m from the company description.   EBITDA • 2021: Full year EBITDA of DKK 1.7-2.3m, compared to latest guidance of DKK 6.2m.  • 2022: Full year EBITDA of DKK 4.0-8.0m, compared to DKK 12.3m

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 121 - 22 DECEMBER 2021 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

Sitowise and Insinööritoimisto Jorma Jääskeläinen Oy join forces

SITOWISE GROUP PLC INVESTOR NEWS 22 DECEMBER 2021 Sitowise has acquired Tampere-based Insinööritoimisto Jorma Jääskeläinen Oy, who specialise in structural engineering and consulting. ”Insinööritoimisto Jorma Jääskeläinen Oy is a respected company, whose expertise is an excellent complement to our service offering, and who strengthen our structural engineering especially in the Tampere region of Finland. We’ve collaborated in projects in the past and want to offer a productive growth environment for the talent of Insinööritoimisto Jorma Jääskeläinen”, says Sitowise’s Building

There are no items matching the current filter
There are no more items matching the current filter
Back to top